Vireo Growth (VREOF) Amortizatization of Intangibles (2020 - 2026)

Vireo Growth's (VREOF) quarterly Amortizatization of Intangibles came in at $2.7 million in Q1 2026, up 2600.0% year-on-year from $100000.0 in Q1 2025, and up 216.11% quarter-over-quarter from -$2.3 million in Q4 2025.

Vireo Growth (VREOF) Amortizatization of Intangibles (2020 - 2026) Analysis & Trends

Vireo Growth has disclosed Amortizatization of Intangibles across 7 years of filings, most recently posting $2.7 million for Q1 2026.

  • Amortizatization of Intangibles for Q1 2026 came in at $2.7 million, up 2600.0% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 million (up 239.36% YoY), and the FY2025 annual result was $99116.0, down 86.24% from the prior year.
  • Amortizatization of Intangibles came in at $2.7 million for Q1 2026 at Vireo Growth, up from -$2.3 million in the prior quarter.
  • In the past five years, Amortizatization of Intangibles ranged from a high of $2.7 million in Q1 2026 to a low of -$2.3 million in Q4 2025.
  • The 5-year median for Amortizatization of Intangibles is $172267.0 (2022), against an average of $405990.8.
  • Across the five-year window, Amortizatization of Intangibles plunged 1391.69% in 2025 and surged 2600.0% in 2026, its largest moves.
  • Vireo Growth's Amortizatization of Intangibles stood at $159766.0 in 2022, then soared by 507.06% to $969875.0 in 2023, then slumped by 81.44% to $180033.0 in 2024, then slumped by 1391.69% to -$2.3 million in 2025, then surged by 216.11% to $2.7 million in 2026.
  • The last three Amortizatization of Intangibles figures came in at $2.7 million (Q1 2026), -$2.3 million (Q4 2025), and $2.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Amortizatization of Intangibles (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn -
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn -
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn -
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 1.30 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn -
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn -
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn -
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 242,000.00
10 Vireo Growth - - 59.30 Mn 2.70 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.70 Mn
Mar 31, 2026 2.70 Mn
Dec 31, 2025 -2.33 Mn
Dec 31, 2025 -2.33 Mn
Sep 30, 2025 2.38 Mn
Sep 30, 2025 2.38 Mn
Jun 30, 2025 -59,864.00
Jun 30, 2025 -59,864.00
Mar 31, 2025 100,000.00
Mar 31, 2025 100,000.00
Dec 31, 2024 180,033.00
Dec 31, 2024 180,033.00
Sep 30, 2024 180,034.00
Sep 30, 2024 180,034.00
Jun 30, 2024 335,289.00
Jun 30, 2024 335,289.00
Mar 31, 2024 24,778.00
Mar 31, 2024 24,778.00
Dec 31, 2023 969,875.00
Dec 31, 2023 969,875.00